DIHYDROMORPHINE

- Everything we could find out about it

Home ] [ Controlled Substances ] [ Opioids ]

Created May 2019 | Updated Nov 2020

DIHYDROMORPHINE

  • [PARAMORFAN]
  • [PARAMORPHAN]

DEA CODE 9145: Schedule 1 Narcotic

Dihydromorphine is a semi-synthetic opioid derived from morphine. Dihydromorphine is a moderately strong analgesic and is used clinically in the treatment of pain and is also the active metabolite of dihydrocodeine.

Dihydromorphine:
It is a moderately strong pain reliever and is used clinically in the treatment of pain and is also the active metabolite of dihydrocodeine. The process for manufacturing dihydromorphine from morphine for pharmaceutical use was developed in Germany in the late 19th Century, with the synthesis being published in 1900 and the drug introduced clinically as Paramorfan shortly thereafter. Dihydromorphine is slightly stronger than morphine as an analgesic with a similar side effect profile. It is also slighty stronger than codeine.

  
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential - There is growing interest in the design and evaluation of peptide drugs for use in humans 35. Indeed, there is increasing activity in the development of NOP peptides (see below) and the use of N ...
Tuesday July 25, 2023 - nature.com

Personalized Therapy in Pain Management: Where do we Stand? - [8,203] This varying metabolic capacity can have considerable impact on the efficacy, tolerability and dosing regimes of various drugs in different ethnic populations. Opioids are the mainstay of ...
Saturday January 27, 2024 - medscape.com

  
Opioids | Link to this page

Home ] [ Controlled Substances ] [ Sources ]


· Controlled Substances
· Opioids
· Dihydromorphine